<p>BALB/c mice were immunized with J8-DT/DT or PBS parenterally. For <i>in vivo</i> depletion of CD8<sup>+</sup> T-cells mice were administered with 1 mg of anti-CD8 (α-CD8-beta clone 53.5.8) mAb intraperitoneally over a set time-course before and after GAS challenge. Survival in J8-DT immunized and CD8<sup>+</sup> T-cell depleted/undepleted BALB/c mice are shown. The abbreviation D stands for immunized/depleted mice whereas U/D represents immunized/undepleted. Significance is represented as * p<0.05 and ** p<0.01.</p
<p>WT B6 mice, H-2K<sup>b</sup> KO mice, β2m KO mice, IFN-γ/Prf double KO mice and MHC class II KO m...
<p>(A) C57BL/6 mice (wt), (B) mice depleted of CD4+ and CD8+ T cells, (C) depleted of CD8+ T cells, ...
<p>(A-C) Analysis of antiviral CD8 T cell effector functions. (A) <i>In vivo</i> cytotoxicity, <i>ex...
<p>BALB/c mice were immunized with J8-DT/DT or PBS parenterally. For <i>in vivo</i> depletion of CD4...
<p>(a) J8-specific serum IgG concentrations in donor BALB/c or recipient SCID mice. Serum samples we...
<p>Mice were immunized as described in <a href="http://www.plosntds.org/article/info:doi/10.1371/jou...
<p>(a) J8-specific IgG concentrations in serum of individual donor and recipient mice are shown, wit...
(A-C) Naïve mice were treated i.p. with a total of 10μg of: anti-CD8α only, anti-CD8β only, or 5μg o...
<p>Control and M2<sub>82</sub>-immunized mice were challenged with either RSV or a 5 LD<sub>50</sub>...
<p>CBA/J mice were infected with an aerosolized dose of <i>Mtb</i> and from day 90–120 were treated ...
(A-B) 106 CD45.1 OT1 T cells were transferred i.v. into CD45.2+ mice, treated i.p. with 500μg of ant...
(A-B) 106 CD45.1+ OT1 T cells were transferred i.v. into CD45.2+ mice, treated with anti-CD8α or –β ...
<p>(A) Flow cytometry analysis. Groups of C57BL/6 mice were injected with rat IgG, anti-CD4 or anti-...
<p>B6, <i>MyD88<sup>−/−</sup></i> and <i>MyD88<sup>−/−</sup>Gt</i> mice were immunized intravenously...
<p><b>a</b>) WT B6 mice were vaccinated with Ad-YF C,M,E or Ad-YF NS3 and intracranial challenged wi...
<p>WT B6 mice, H-2K<sup>b</sup> KO mice, β2m KO mice, IFN-γ/Prf double KO mice and MHC class II KO m...
<p>(A) C57BL/6 mice (wt), (B) mice depleted of CD4+ and CD8+ T cells, (C) depleted of CD8+ T cells, ...
<p>(A-C) Analysis of antiviral CD8 T cell effector functions. (A) <i>In vivo</i> cytotoxicity, <i>ex...
<p>BALB/c mice were immunized with J8-DT/DT or PBS parenterally. For <i>in vivo</i> depletion of CD4...
<p>(a) J8-specific serum IgG concentrations in donor BALB/c or recipient SCID mice. Serum samples we...
<p>Mice were immunized as described in <a href="http://www.plosntds.org/article/info:doi/10.1371/jou...
<p>(a) J8-specific IgG concentrations in serum of individual donor and recipient mice are shown, wit...
(A-C) Naïve mice were treated i.p. with a total of 10μg of: anti-CD8α only, anti-CD8β only, or 5μg o...
<p>Control and M2<sub>82</sub>-immunized mice were challenged with either RSV or a 5 LD<sub>50</sub>...
<p>CBA/J mice were infected with an aerosolized dose of <i>Mtb</i> and from day 90–120 were treated ...
(A-B) 106 CD45.1 OT1 T cells were transferred i.v. into CD45.2+ mice, treated i.p. with 500μg of ant...
(A-B) 106 CD45.1+ OT1 T cells were transferred i.v. into CD45.2+ mice, treated with anti-CD8α or –β ...
<p>(A) Flow cytometry analysis. Groups of C57BL/6 mice were injected with rat IgG, anti-CD4 or anti-...
<p>B6, <i>MyD88<sup>−/−</sup></i> and <i>MyD88<sup>−/−</sup>Gt</i> mice were immunized intravenously...
<p><b>a</b>) WT B6 mice were vaccinated with Ad-YF C,M,E or Ad-YF NS3 and intracranial challenged wi...
<p>WT B6 mice, H-2K<sup>b</sup> KO mice, β2m KO mice, IFN-γ/Prf double KO mice and MHC class II KO m...
<p>(A) C57BL/6 mice (wt), (B) mice depleted of CD4+ and CD8+ T cells, (C) depleted of CD8+ T cells, ...
<p>(A-C) Analysis of antiviral CD8 T cell effector functions. (A) <i>In vivo</i> cytotoxicity, <i>ex...